Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Frits Rosendaal
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Concepts & Ideas
Procedures
Chemicals & Drugs
Physiology
Geographic Areas
Anatomy
Genes & Molecular Sequences
Sign-in to see full Profile
Network (preview)
51
Doggen, C J M
48
Bertina, Rogier
33
van der Meer, Felix
31
Psaty, Bruce
30
Vos, Hans
23
Helmerhorst, Frans
22
cannegieter, suzanne
21
Vandenbroucke, Jan
20
Vossen, Carla
19
Algra, Ale
18
Reitsma, Pieter
17
Heckbert, Susan
17
Van Hylckama Vlieg, Astrid
16
Bovill, Edwin
16
Siscovick, David
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Frits Rosendaal (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Urbanus Rolf T; Siegerink Bob; Roest Mark; Rosendaal Frits R; de Groot Philip G; Algra Ale
Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study.
Lancet neurology 2009;8(11):998-1005.
-
2009: de Jager Dinanda J; Grootendorst Diana C; Jager Kitty J; van Dijk Paul C; Tomas Lonneke M J; Ansell David; Collart Frederic; Finne Patrik; Heaf James G; De Meester Johan; Wetzels Jack F M; Rosendaal Frits R; Dekker Friedo W
Cardiovascular and noncardiovascular mortality among patients starting dialysis.
JAMA : the journal of the American Medical Association 2009;302(16):1782-9.
-
2009: van Schie Rianne M F; Wadelius M I A; Kamali Farhad; Daly Ann K; Manolopoulos Vangelis G; de Boer Anthonius; Barallon Rita; Verhoef Talitha I; Kirchheiner Julia; Haschke-Becher Elisabeth; Briz Montserrat; Rosendaal Frits R; Redekop William K; Pirmohamed Munir; van der Zee Anke-Hilse Maitland
Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design.
Pharmacogenomics 2009;10(10):1687-95.
-
2009: de Laat Bas; de Groot Philip G; Derksen Ronald H W M; Urbanus Rolf T; Mertens Koen; Rosendaal Frits R; Doggen Carine J M
Association between beta2-glycoprotein I plasma levels and the risk of myocardial infarction in older men.
Blood 2009;114(17):3656-61.
-
2009: Hasstedt Sandra J; Bezemer Irene D; Callas Peter W; Vossen Carla Y; Trotman Winifred; Hebbel Robert P; Demers Christine; Rosendaal Frits R; Bovill Edwin G
Cell adhesion molecule 1: a novel risk factor for venous thrombosis.
Blood 2009;114(14):3084-91.
-
2009: Borleffs C Jan Willem; van Erven Lieselot; van Bommel Rutger J; van der Velde Enno T; van der Wall Ernst E; Bax Jeroen J; Rosendaal Frits R; Schalij Martin J
Risk of failure of transvenous implantable cardioverter-defibrillator leads.
Circulation. Arrhythmia and electrophysiology 2009;2(4):411-6.
-
2009: Darwish Murad Sarwa; Plessier Aurelie; Hernandez-Guerra Manuel; Fabris Federica; Eapen Chundamannil E; Bahr Matthias J; Trebicka Jonel; Morard Isabelle; Lasser Luc; Heller Joerg; Hadengue Antoine; Langlet Philippe; Miranda Helena; Primignani Massimo; Elias Elwyn; Leebeek Frank W; Rosendaal Frits R; Garcia-Pagan Juan-Carlos; Valla Dominique C; Janssen Harry L A;
Etiology, management, and outcome of the Budd-Chiari syndrome.
Annals of internal medicine 2009;151(3):167-75.
-
2009: Siegerink Bob; Algra Ale; Rosendaal Frits R
Genetic variants of coagulation factor XIII and the risk of myocardial infarction in young women.
British journal of haematology 2009;146(4):459-61.
-
2009: Vandenbroucke Jan P; Cannegieter Suzanne C; Rosendaal Frits R
Travel and venous thrombosis: an exercise in thinking about bias.
Annals of internal medicine 2009;151(3):212-3.
-
2009: Klok Frederikus A; Mos Inge C M; Broek Lisette; Tamsma Jouke T; Rosendaal Frits R; de Roos Albert; Huisman Menno V
Risk of arterial cardiovascular events in patients after pulmonary embolism.
Blood 2009;114(8):1484-8.
-
2009: Botha-Scheepers S; Riyazi N; Watt I; Rosendaal F R; Slagboom E; Bellamy N; Breedveld F C; Kloppenburg M
Progression of hand osteoarthritis over 2 years: a clinical and radiological follow-up study.
Annals of the rheumatic diseases 2009;68(8):1260-4.
-
2009: Meltzer Mirjam E; Doggen Carine J M; de Groot Philip G; Rosendaal Frits R; Lisman Ton
The impact of the fibrinolytic system on the risk of venous and arterial thrombosis.
Seminars in thrombosis and hemostasis 2009;35(5):468-77.
-
2009: Kamphuisen Pieter W; Rosendaal Frits R; Büller Harry R
Hemostatic abnormalities and arterial thrombosis.
Seminars in thrombosis and hemostasis 2009;35(5):449-50.
-
2009: Rosendaal F R; Reitsma P H
Genetics of venous thrombosis.
Journal of thrombosis and haemostasis : JTH 2009;7 Suppl 1():301-4.
-
2009: Brummel-Ziedins K E; Orfeo T; Rosendaal F R; Undas A; Rivard G E; Butenas S; Mann K G
Empirical and theoretical phenotypic discrimination.
Journal of thrombosis and haemostasis : JTH 2009;7 Suppl 1():181-6.
-
2009: Torn Marieke; Cannegieter Suzanne C; Bollen Ward L E M; van der Meer Felix J M; van der Wall Ernst E; Rosendaal Frits R
Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients.
Archives of internal medicine 2009;169(13):1203-9.
-
2009: Meltzer Mirjam E; Doggen Carine J M; de Groot Philip G; Meijers Joost C M; Rosendaal Frits R; Lisman Ton
Low thrombin activatable fibrinolysis inhibitor activity levels are associated with an increased risk of a first myocardial infarction in men.
Haematologica 2009;94(6):811-8.
-
2009: Bergheanu Sandrin C; Pons Douwe; Jukema J Wouter; van der Hoeven Bas L; Liem Su-San; Vandenbroucke Jan P; Rosendaal Frits R; le Cessie Saskia; Schalij Martin J; van der Bom Johanna G
Myocardial infarction occurs with a similar 24 h pattern in the 4G/5G versions of plasminogen activator inhibitor-1.
Chronobiology international 2009;26(4):637-52.
-
2009: Bezemer Irene D; Arellano Andre R; Tong Carmen H; Rowland Charles M; Ireland Helen A; Bauer Kenneth A; Catanese Joseph; Reitsma Pieter H; Doggen Carine J M; Devlin James J; Rosendaal Frits R; Bare Lance A
F9 Malmö, factor IX and deep vein thrombosis.
Haematologica 2009;94(5):693-9.
-
2009: Pruissen D M O; Kappelle L J; Rosendaal F R; Algra A;
Prothrombotic genetic variants and atherosclerosis in patients with cerebral ischemia of arterial origin.
Atherosclerosis 2009;204(1):191-5.
-
2009: van Vliet Huib A A M; Tchaikovski Svetlana N; Rosendaal Frits R; Rosing Jan; Helmerhorst Frans M
The effect of the levonorgestrel-releasing intrauterine system on the resistance to activated protein C (APC).
Thrombosis and haemostasis 2009;101(4):691-5.
-
2009: van Vliet Huib A A M; Rosendaal Frits R; Rosing Jan; Helmerhorst Frans M
Sex hormone-binding globulin: an adequate surrogate marker for venous thromboembolism in women using new hormonal contraceptives.
Contraception 2009;79(4):328-9; author reply 329-30.
-
2009: Meltzer Mirjam E; Doggen Carine J M; de Groot Philip G; Rosendaal Frits R; Lisman Ton
Reduced plasma fibrinolytic capacity as a potential risk factor for a first myocardial infarction in young men.
British journal of haematology 2009;145(1):121-7.
-
2009: Ramcharan A S; Van Stralen K J; Snoep J D; Mantel-Teeuwisse A K; Rosendaal F R; Doggen C J M
HMG-CoA reductase inhibitors, other lipid-lowering medication, antiplatelet therapy, and the risk of venous thrombosis.
Journal of thrombosis and haemostasis : JTH 2009;7(4):514-20.
-
2009: Bezemer Irene D; van der Meer Felix J M; Eikenboom Jeroen C J; Rosendaal Frits R; Doggen Carine J M
The value of family history as a risk indicator for venous thrombosis.
Archives of internal medicine 2009;169(6):610-5.
-
2009: Rombouts Eva K; Rosendaal Frits R; van der Meer Felix J M
Subtherapeutic oral anticoagulant therapy: frequency and risk factors.
Thrombosis and haemostasis 2009;101(3):552-6.
-
2009: Wichers Iris M; Tanck Michael W T; Meijers Joost C M; Lisman Ton; Reitsma Pieter H; Rosendaal Frits R; Büller Harry R; Middeldorp Saskia
Assessment of coagulation and fibrinolysis in families with unexplained thrombophilia.
Thrombosis and haemostasis 2009;101(3):465-70.
-
2009: Siegerink B; Rosendaal F R; Algra A
Genetic variation in fibrinogen; its relationship to fibrinogen levels and the risk of myocardial infarction and ischemic stroke.
Journal of thrombosis and haemostasis : JTH 2009;7(3):385-90.
-
2009: van der Bom J G; Heckbert S R; Lumley T; Holmes C E; Cushman M; Folsom A R; Rosendaal F R; Psaty B M
Platelet count and the risk for thrombosis and death in the elderly.
Journal of thrombosis and haemostasis : JTH 2009;7(3):399-405.
-
2009: van Minkelen Rick; Wettinger Stephanie Bezzina; de Visser Marieke C H; Vos Hans L; Reitsma Pieter H; Rosendaal Frits R; Bertina Rogier M; Doggen Carine J M
Haplotypes of the interleukin-1 receptor antagonist gene, interleukin-1 receptor antagonist mRNA levels and the risk of myocardial infarction.
Atherosclerosis 2009;203(1):201-5.
-
2009: Schreijer Anja J M; Cannegieter Suzanne C; Doggen Carine J M; Rosendaal Frits R
The effect of flight-related behaviour on the risk of venous thrombosis after air travel.
British journal of haematology 2009;144(3):425-9.
-
2009: Wiggins K L; Smith N L; Glazer N L; Rosendaal F R; Heckbert S R; Psaty B M; Rice K M; Lumley T
ABO genotype and risk of thrombotic events and hemorrhagic stroke.
Journal of thrombosis and haemostasis : JTH 2009;7(2):263-9.
-
2009: Kuipers Saskia; Cannegieter Suzanne C; Doggen Carine J M; Rosendaal Frits R
Effect of elevated levels of coagulation factors on the risk of venous thrombosis in long-distance travelers.
Blood 2009;113(9):2064-9.
-
2009: Hindorff Lucia A; Burke Wylie; Laberge Anne-Marie; Rice Kenneth M; Lumley Thomas; Leppig Kathleen; Rosendaal Frits R; Larson Eric B; Psaty Bruce M
Motivating factors for physician ordering of factor V Leiden genetic tests.
Archives of internal medicine 2009;169(1):68-74.
-
2009: Pomp Elisabeth R; Doggen Carine J M; Vos Hans L; Reitsma Pieter H; Rosendaal Frits R
Polymorphisms in the protein C gene as risk factor for venous thrombosis.
Thrombosis and haemostasis 2009;101(1):62-7.
-
2009: van Hylckama Vlieg A; Helmerhorst F M; Vandenbroucke J P; Doggen C J M; Rosendaal F R
The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study.
BMJ (Clinical research ed.) 2009;339():b2921.
-
2009: Pruissen D Martijn O; Kappelle L Jaap; Rosendaal Frits R; Algra Ale
Genetic association studies in ischaemic stroke: replication failure and prospects.
Cerebrovascular diseases (Basel, Switzerland) 2009;27(3):290-4.
-
2008: Botha-Scheepers Stella; Watt Iain; Rosendaal Frits R; Breedveld Ferdinand C; Hellio le Graverand Marie-Pierre; Kloppenburg Margreet
Changes in outcome measures for impairment, activity limitation, and participation restriction over two years in osteoarthritis of the lower extremities.
Arthritis and rheumatism 2008;59(12):1750-5.
-
2008: le Cessie Saskia; Nagelkerke Nico; Rosendaal Frits R; van Stralen Karlijn J; Pomp Elisabeth R; van Houwelingen Hans C
Combining matched and unmatched control groups in case-control studies.
American journal of epidemiology 2008;168(10):1204-10.
-
2008: Rosendaal Frits R
Hormone replacement therapy and thrombotic risk: beauty is only skin deep.
Nature clinical practice. Cardiovascular medicine 2008;5(11):684-5.
-
2008: Paffen E; Medina P; de Visser M C H; van Wijngaarden A; Zorio E; Estellés A; Rosendaal F R; España F; Bertina R M; Doggen C J M
The -589C>T polymorphism in the interleukin-4 gene (IL-4) is associated with a reduced risk of myocardial infarction in young individuals.
Journal of thrombosis and haemostasis : JTH 2008;6(10):1633-8.
-
2008: Pruissen D M O; Rosendaal F R; Frijns C J M; Kappelle L J; Vos H L; Algra A;
Prothrombotic gene variation and new vascular events after cerebral ischemia of arterial origin.
Journal of thrombosis and haemostasis : JTH 2008;6(10):1639-44.
-
2008: van Stralen K J; Doggen C J M; Bezemer I D; Pomp E R; Lisman T; Rosendaal F R
Mechanisms of the factor V Leiden paradox.
Arteriosclerosis, thrombosis, and vascular biology 2008;28(10):1872-7.
-
2008: Flinterman L E; van Hylckama Vlieg A; Rosendaal F R; Doggen C J M
Recurrent thrombosis and survival after a first venous thrombosis of the upper extremity.
Circulation 2008;118(13):1366-72.
-
2008: Coppens M; Reijnders J H; Middeldorp S; Doggen C J M; Rosendaal F R
Testing for inherited thrombophilia does not reduce the recurrence of venous thrombosis.
Journal of thrombosis and haemostasis : JTH 2008;6(9):1474-7.
-
2008: Flinterman L E; Van Der Meer F J M; Rosendaal F R; Doggen C J M
Current perspective of venous thrombosis in the upper extremity.
Journal of thrombosis and haemostasis : JTH 2008;6(8):1262-6.
-
2008: Botha-Scheepers S; Watt I; Slagboom E; de Craen A J M; Meulenbelt I; Rosendaal F R; Breedveld F C; Huizinga T W J; Kloppenburg M
Innate production of tumour necrosis factor alpha and interleukin 10 is associated with radiological progression of knee osteoarthritis.
Annals of the rheumatic diseases 2008;67(8):1165-9.
-
2008: Schreijer Anja J M; Cannegieter Suzanne C; Caramella Marianna; Meijers Joost C M; Krediet Raymond T; Simons Ries M; Rosendaal Frits R
Fluid loss does not explain coagulation activation during air travel.
Thrombosis and haemostasis 2008;99(6):1053-9.
-
2008: Nossent A Yaël; Vos Hans L; Rosendaal Frits R; Bertina Rogier M; Eikenboom Jeroen C J
Aquaporin 2 gene variations, risk of venous thrombosis and plasma levels of von Willebrand factor and factor VIII.
Haematologica 2008;93(6):959-60.
-
2008: Riyazi N; Rosendaal F R; Slagboom E; Kroon H M; Breedveld F C; Kloppenburg M
Risk factors in familial osteoarthritis: the GARP sibling study.
Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society 2008;16(6):654-9.
-
2008: Meltzer Mirjam E; Lisman Ton; Doggen Carine J M; de Groot Philip G; Rosendaal Frits R
Synergistic effects of hypofibrinolysis and genetic and acquired risk factors on the risk of a first venous thrombosis.
PLoS medicine 2008;5(5):e97.
-
2008: Verschuur Margot J; Spinhoven Philip; Rosendaal Frits R
Offering a medical examination following disaster exposure does not result in long-lasting reassurance about health complaints.
General hospital psychiatry 2008;30(3):200-7.
-
2008: Naess Inger Anne; Christiansen Sverre C; Romundstad Pål R; Cannegieter Suzanne C; Blom Henk J; Rosendaal Frits R; Hammerstrøm Jens
Prospective study of homocysteine and MTHFR 677TT genotype and risk for venous thrombosis in a general population--results from the HUNT 2 study.
British journal of haematology 2008;141(4):529-35.
-
2008: Levi Marcel; Hovingh G Kees; Cannegieter Suzanne C; Vermeulen Marinus; Büller Harry R; Rosendaal Frits R
Bleeding in patients receiving vitamin K antagonists who would have been excluded from trials on which the indication for anticoagulation was based.
Blood 2008;111(9):4471-6.
-
2008: van der Krabben M D; Rosendaal F R; van der Bom J G; Doggen C J M
Polymorphisms in coagulation factors and the risk of recurrent cardiovascular events in men after a first myocardial infarction.
Journal of thrombosis and haemostasis : JTH 2008;6(5):720-5.
-
2008: van Hylckama Vlieg A; Baglin C A; Bare L A; Rosendaal F R; Baglin T P
Proof of principle of potential clinical utility of multiple SNP analysis for prediction of recurrent venous thrombosis.
Journal of thrombosis and haemostasis : JTH 2008;6(5):751-4.
-
2008: Pomp E R; Lenselink A M; Rosendaal F R; Doggen C J M
Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study.
Journal of thrombosis and haemostasis : JTH 2008;6(4):632-7.
-
2008: Bezemer Irene D; Bare Lance A; Doggen Carine J M; Arellano Andre R; Tong Carmen; Rowland Charles M; Catanese Joseph; Young Bradford A; Reitsma Pieter H; Devlin James J; Rosendaal Frits R
Gene variants associated with deep vein thrombosis.
JAMA : the journal of the American Medical Association 2008;299(11):1306-14.
-
2008: Uitte de Willige S; De Visser M C H; Vos H L; Houwing-Duistermaat J J; Rosendaal F R; Bertina R M
Selectin haplotypes and the risk of venous thrombosis: influence of linkage disequilibrium with the factor V Leiden mutation.
Journal of thrombosis and haemostasis : JTH 2008;6(3):478-85.
-
2008: van Stralen Karlijn J; Doggen Carine J M; Lumley Thomas; Cushman Mary; Folsom Aaron R; Psaty Bruce M; Siscovick David; Rosendaal Frits R; Heckbert Susan R
The relationship between exercise and risk of venous thrombosis in elderly people.
Journal of the American Geriatrics Society 2008;56(3):517-22.
-
2008: van Leeuwen Y; Rosendaal F R; Cannegieter S C
Prediction of hemorrhagic and thrombotic events in patients with mechanical heart valve prostheses treated with oral anticoagulants.
Journal of thrombosis and haemostasis : JTH 2008;6(3):451-6.
-
2008: van Vliet H A A M; Bertina R M; Dahm A E A; Rosendaal F R; Rosing J; Sandset P Morten; Helmerhorst F M
Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitor.
Journal of thrombosis and haemostasis : JTH 2008;6(2):346-51.
-
2008: Dahm A E A; Sandset P M; Rosendaal F R
The association between protein S levels and anticoagulant activity of tissue factor pathway inhibitor type 1.
Journal of thrombosis and haemostasis : JTH 2008;6(2):393-5.
-
2008: Pruissen D Martijn O; Slooter Arjen J C; Rosendaal Frits R; van der Graaf Yolanda; Algra Ale
Coagulation factor XIII gene variation, oral contraceptives, and risk of ischemic stroke.
Blood 2008;111(3):1282-6.
-
2008: Plug Iris; Peters Marjolein; Mauser-Bunschoten Eveline P; de Goede-Bolder Arja; Heijnen Lily; Smit Cees; Willemse José; Rosendaal Frits R; van der Bom Johanna G
Social participation of patients with hemophilia in the Netherlands.
Blood 2008;111(4):1811-5.
-
2008: Verschuur Margot J; Spinhoven Philip; van Emmerik Arnold A P; Rosendaal Frits R
Participation in a trauma-focused epidemiological investigation may result in sensitization for current health problems.
Social psychiatry and psychiatric epidemiology 2008;43(2):132-9.
-
2008: Pomp Elisabeth R; Rosendaal Frits R; Doggen Carine J M
Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use.
American journal of hematology 2008;83(2):97-102.
-
2008: Pomp Elisabeth R; Rosendaal Frits R; Doggen Carine J M
Alcohol consumption is associated with a decreased risk of venous thrombosis.
Thrombosis and haemostasis 2008;99(1):59-63.
-
2008: van Rooden Cornelis J; Schippers Emile F; Guiot Henri F L; Barge Renée M; Hovens Marcel M C; van der Meer Felix J M; Rosendaal Frits R; Huisman Menno V
Prevention of coagulase-negative staphylococcal central venous catheter-related infection using urokinase rinses: a randomized double-blind controlled trial in patients with hematologic malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(3):428-33.
-
2008: van Stralen Karlijn J; Rosendaal Frits R; Doggen Carine J M
Minor injuries as a risk factor for venous thrombosis.
Archives of internal medicine 2008;168(1):21-6.
-
2008: Pruissen D Martijn O; Kappelle L Jaap; Rosendaal Frits R; Algra Ale;
Prothrombotic gene variation in patients with large and small vessel disease.
Neuroepidemiology 2008;31(2):89-92.
-
2008: van Leeuwen Yvonne; Rosendaal Frits R; van der Meer Felix J M
The relationship between maintenance dosages of three vitamin K antagonists: acenocoumarol, warfarin and phenprocoumon.
Thrombosis research 2008;123(2):225-30.
-
2008: van Vliet Huib A A M; Rodrigues Sharon P; Snieders Marieke N E; van der Meer Felix J M; Frolich Marijke; Rosendaal Frits R; Rosing Jan; Helmerhorst Frans M
Sensitivity to activated protein C during the menstrual cycle in women with and without factor VLeiden.
Thrombosis research 2008;121(6):757-61.
-
2007: Tchaikovski Svetlana N; van Vliet Huib A A M; Thomassen M C L G D; Bertina Rogier M; Rosendaal Frits R; Sandset Per-Morten; Helmerhorst Frans M; Tans Guido; Rosing Jan
Effect of oral contraceptives on thrombin generation measured via calibrated automated thrombography.
Thrombosis and haemostasis 2007;98(6):1350-6.
-
2007: Pons Douwe; Monraats Pascalle S; de Maat Moniek P M; Pires Nuno M M; Quax Paul H A; van Vlijmen Bart J M; Rosendaal Frits R; Zwinderman Aeilko H; Doevendans Pieter A F M; Waltenberger Johannes; de Winter Robbert J; Tio René A; Frants Rune R; van der Laarse Arnoud; van der Wall Ernst E; Jukema J Wouter
The influence of established genetic variation in the haemostatic system on clinical restenosis after percutaneous coronary interventions.
Thrombosis and haemostasis 2007;98(6):1323-8.
-
2007: Kuipers S; Schreijer A J M; Cannegieter S C; Büller H R; Rosendaal F R; Middeldorp S
Travel and venous thrombosis: a systematic review.
Journal of internal medicine 2007;262(6):615-34.
-
2007: Kaptein Ad A; van Korlaar Inez M; Cameron Linda D; Vossen Carla Y; van der Meer Felix J M; Rosendaal Frits R
Using the common-sense model to predict risk perception and disease-related worry in individuals at increased risk for venous thrombosis.
Health psychology : official journal of the Division of Health Psychology, American Psychological Association 2007;26(6):807-12.
-
2007: van Stralen K J; Le Cessie S; Rosendaal F R; Doggen C J M
Regular sports activities decrease the risk of venous thrombosis.
Journal of thrombosis and haemostasis : JTH 2007;5(11):2186-92.
-
2007: Nagai Nobuo; Lijnen H Roger; Cleuren Audrey C A; Rosendaal Frits R; Van Hoef Berthe; Hoylaerts Marc F; Van Vlijmen Bart J M
Factor V Leiden mutation is associated with enhanced arterial thrombotic tendency in lean but not in obese mice.
Thrombosis and haemostasis 2007;98(4):858-63.
-
2007: Pomp Elisabeth R; le Cessie Saskia; Rosendaal Frits R; Doggen Carine J M
Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations.
British journal of haematology 2007;139(2):289-96.
-
2007: Rombouts E K; Rosendaal F R; Van Der Meer F J M
Daily vitamin K supplementation improves anticoagulant stability.
Journal of thrombosis and haemostasis : JTH 2007;5(10):2043-8.
-
2007: Kuipers Saskia; Cannegieter Suzanne C; Middeldorp Saskia; Robyn Luc; Büller Harry R; Rosendaal Frits R
The absolute risk of venous thrombosis after air travel: a cohort study of 8,755 employees of international organisations.
PLoS medicine 2007;4(9):e290.
-
2007: Hasstedt Sandra J; Scott Bruce T; Rosendaal Frits R; Callas Peter W; Vossen Carla Y; Long George L; Bovill Edwin G
Exclusion of the alpha2 subunit of platelet-activating factor acetylhydrolase 1b (PAFAH1B2) as a prothrombotic gene in a protein C-deficient kindred and population-based case-control sample.
Thrombosis and haemostasis 2007;98(3):587-92.
-
2007: van Hylckama Vlieg A; Christiansen S C; Luddington R; Cannegieter S C; Rosendaal F R; Baglin T P
Elevated endogenous thrombin potential is associated with an increased risk of a first deep venous thrombosis but not with the risk of recurrence.
British journal of haematology 2007;138(6):769-74.
-
2007: Vossen C Y; Callas P W; Hasstedt S J; Long G L; Rosendaal F R; Bovill E G
A genetic basis for the interrelation of coagulation factors.
Journal of thrombosis and haemostasis : JTH 2007;5(9):1930-5.
-
2007: van Leeuwen Y; Rombouts E K; Kruithof C J; van der Meer F J M; Rosendaal F R
Improved control of oral anticoagulant dosing: a randomized controlled trial comparing two computer algorithms.
Journal of thrombosis and haemostasis : JTH 2007;5(8):1644-9.
-
2007: van Dijk J Marc C; TerBrugge Karel G; Van der Meer Felix J; Wallace M Christopher; Rosendaal Frits R
Thrombophilic factors and the formation of dural arteriovenous fistulas.
Journal of neurosurgery 2007;107(1):56-9.
-
2007: Rosendaal F R; VAN Hylckama Vlieg A; Doggen C J M
Venous thrombosis in the elderly.
Journal of thrombosis and haemostasis : JTH 2007;5 Suppl 1():310-7.
-
2007: Reitsma P H; Rosendaal F R
Past and future of genetic research in thrombosis.
Journal of thrombosis and haemostasis : JTH 2007;5 Suppl 1():264-9.
-
2007: Coppens M; Schreijer A J M; Berger F H; Cannegieter S C; Rosendaal F R; Büller H R
Mechanical prophylaxis for travellers' thrombosis: a comparison of three interventions that promote venous outflow.
Journal of thrombosis and haemostasis : JTH 2007;5(7):1556-67.
-
2007: van Hylckama Vlieg A; Montes R; Rosendaal F R; Hermida J
Autoantibodies against endothelial protein C receptor and the risk of a first deep vein thrombosis.
Journal of thrombosis and haemostasis : JTH 2007;5(7):1449-54.
-
2007: van Minkelen Rick; de Visser Marieke C H; Houwing-Duistermaat Jeanine J; Vos Hans L; Bertina Rogier M; Rosendaal Frits R
Haplotypes of IL1B, IL1RN, IL1R1, and IL1R2 and the risk of venous thrombosis.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(6):1486-91.
-
2007: Vossen C Y; Hasstedt S J; Demers C; Rosendaal F R; Bovill E G
Linkage analysis for three coagulation factors clustering on chromosome 13q34: factor VII, factor X and protein Z.
Journal of thrombosis and haemostasis : JTH 2007;5(6):1325-7.
-
2007: Botha-Scheepers Stella A; Watt Iain; Slagboom Eline; Meulenbelt Ingrid; Rosendaal Frits R; Breedveld Ferdinand C; Kloppenburg Margreet
Influence of familial factors on radiologic disease progression over two years in siblings with osteoarthritis at multiple sites: a prospective longitudinal cohort study.
Arthritis and rheumatism 2007;57(4):626-32.
-
2007: Meltzer Mirjam E; Doggen Carine J M; de Groot Philip G; Rosendaal Frits R; Lisman Ton
Fibrinolysis and the risk of venous and arterial thrombosis.
Current opinion in hematology 2007;14(3):242-8.
-
2007: Gadisseur A P A; Christiansen S C; VAN DER Meer F J M; Rosendaal F R
The quality of oral anticoagulant therapy and recurrent venous thrombotic events in the Leiden Thrombophilia Study.
Journal of thrombosis and haemostasis : JTH 2007;5(5):931-6.
-
2007: Bezemer Irene D; Rosendaal Frits R
Predictive genetic variants for venous thrombosis: what's new?
Seminars in hematology 2007;44(2):85-92.
-
2007: Morelli Vania M; de Visser Marieke C H; van Tilburg Nico H; Vos Hans L; Eikenboom Jeroen C J; Rosendaal Frits R; Bertina Rogier M
ABO blood group genotypes, plasma von Willebrand factor levels and loading of von Willebrand factor with A and B antigens.
Thrombosis and haemostasis 2007;97(4):534-41.
-
2007: Naess I A; Christiansen S C; Romundstad P; Cannegieter S C; Rosendaal F R; Hammerstrøm J
Incidence and mortality of venous thrombosis: a population-based study.
Journal of thrombosis and haemostasis : JTH 2007;5(4):692-9.
-
2007: Bezemer Irene D; Doggen Carine J M; Vos Hans L; Rosendaal Frits R
No association between the common MTHFR 677C->T polymorphism and venous thrombosis: results from the MEGA study.
Archives of internal medicine 2007;167(5):497-501.
-
2007: Nossent A Y; Eikenboom J C J; Tanis B C; Doggen C J M; Rosendaal F R
Haplotypes encoding the factor VIII 1241Glu variation and the risk of myocardial infarction.
Journal of thrombosis and haemostasis : JTH 2007;5(3):619-21.
-
2007: Chion Chan K N K; Doggen Carine J M; Crawley James T B; Lane David A; Rosendaal Frits R
ADAMTS13 and von Willebrand factor and the risk of myocardial infarction in men.
Blood 2007;109(5):1998-2000.
-
2007: Smith Nicholas L; Hindorff Lucia A; Heckbert Susan R; Lemaitre Rozenn N; Marciante Kristin D; Rice Kenneth; Lumley Thomas; Bis Joshua C; Wiggins Kerri L; Rosendaal Frits R; Psaty Bruce M
Association of genetic variations with nonfatal venous thrombosis in postmenopausal women.
JAMA : the journal of the American Medical Association 2007;297(5):489-98.
-
2007: de Bruijne Emile L E; Darwish Murad Sarwa; de Maat Moniek P M; Tanck Michael W T; Haagsma Elizabeth B; van Hoek Bart; Rosendaal Frits R; Janssen Harry L A; Leebeek Frank W G;
Genetic variation in thrombin-activatable fibrinolysis inhibitor (TAFI) is associated with the risk of splanchnic vein thrombosis.
Thrombosis and haemostasis 2007;97(2):181-5.
-
2007: Bernstein Charles N; Sargent Michael; Vos Hans L; Rosendaal Frits R
Mutations in clotting factors and inflammatory bowel disease.
The American journal of gastroenterology 2007;102(2):338-43.
-
2007: Keijzer Miranda B A J; Borm George F; Blom Henk J; Bos Gerard M J; Rosendaal Frits R; den Heijer Martin
No interaction between factor V Leiden and hyperhomocysteinemia or MTHFR 677TT genotype in venous thrombosis. Results of a meta-analysis of published studies and a large case-only study.
Thrombosis and haemostasis 2007;97(1):32-7.
-
2007: den Heijer Martin; Willems Huub P J; Blom Henk J; Gerrits Wim B J; Cattaneo Marco; Eichinger Sabine; Rosendaal Frits R; Bos Gerard M J
Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: A randomized, placebo-controlled, double-blind trial.
Blood 2007;109(1):139-44.
-
2006: Chinthammitr Y; Vos H L; Rosendaal F R; Doggen C J M
The association of prothrombin A19911G polymorphism with plasma prothrombin activity and venous thrombosis: results of the MEGA study, a large population-based case-control study.
Journal of thrombosis and haemostasis : JTH 2006;4(12):2587-92.
-
2006: Nossent A Y; VAN Marion V; VAN Tilburg N H; Rosendaal F R; Bertina R M; VAN Mourik J A; Eikenboom H C J
von Willebrand factor and its propeptide: the influence of secretion and clearance on protein levels and the risk of venous thrombosis.
Journal of thrombosis and haemostasis : JTH 2006;4(12):2556-62.
-
2006: Smith Nicholas L; Heckbert Susan R; Lemaitre Rozenn N; Reiner Alexander P; Lumley Thomas; Rosendaal Frits R; Psaty Bruce M
Conjugated equine estrogen, esterified estrogen, prothrombotic variants, and the risk of venous thrombosis in postmenopausal women.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(12):2807-12.
-
2006: Doggen Carine J M; Rosendaal Frits R; Meijers Joost C M
Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: Opposite and synergistic effects of factors XI and XII.
Blood 2006;108(13):4045-51.
-
2006: Rosendaal F R
Interventions to prevent venous thrombosis after air travel: are they necessary? No.
Journal of thrombosis and haemostasis : JTH 2006;4(11):2306-7.
-
2006: Kuipers S; Cannegieter S C; Middeldorp S; Rosendaal F R; Büller H R
Use of preventive measures for air travel-related venous thrombosis in professionals who attend medical conferences.
Journal of thrombosis and haemostasis : JTH 2006;4(11):2373-6.
-
2006: Vriesendorp Titia M; DeVries J Hans; van Santen Susanne; Moeniralam Hazra S; de Jonge Evert; Roos Yvo B W E M; Schultz Marcus J; Rosendaal Frits R; Hoekstra Joost B L
Evaluation of short-term consequences of hypoglycemia in an intensive care unit.
Critical care medicine 2006;34(11):2714-8.
-
2006: Botha-Scheepers S; Riyazi N; Kroon H M; Scharloo M; Houwing-Duistermaat J J; Slagboom E; Rosendaal F R; Breedveld F C; Kloppenburg M
Activity limitations in the lower extremities in patients with osteoarthritis: the modifying effects of illness perceptions and mental health.
Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society 2006;14(11):1104-10.
-
2006: van der Hagen P B; Folsom A R; Jenny N S; Heckbert S R; O'Meara E S; Reich L M; Rosendaal F R; Cushman M
Subclinical atherosclerosis and the risk of future venous thrombosis in the Cardiovascular Health Study.
Journal of thrombosis and haemostasis : JTH 2006;4(9):1903-8.
-
2006: Christiansen Sverre C; Naess Inger Anne; Cannegieter Suzanne C; Hammerstrøm Jens; Rosendaal Frits R; Reitsma Pieter H
Inflammatory cytokines as risk factors for a first venous thrombosis: a prospective population-based study.
PLoS medicine 2006;3(8):e334.
-
2006: Cannegieter Suzanne C; Doggen Carine J M; van Houwelingen Hans C; Rosendaal Frits R
Travel-related venous thrombosis: results from a large population-based case control study (MEGA study).
PLoS medicine 2006;3(8):e307.
-
2006: Coppens M; van Doormaal F F; Schreijer A J M; Rosendaal F R; Büller H R
Intermittent mechanical compression for prevention of travellers' thrombosis.
Journal of thrombosis and haemostasis : JTH 2006;4(8):1836-8.
-
2006: Smith N L; Heckbert S R; Doggen C J; Lemaitre R N; Reiner A P; Lumley T; Meijers J C M; Psaty B M; Rosendaal F R
The differential association of conjugated equine estrogen and esterified estrogen with activated protein C resistance in postmenopausal women.
Journal of thrombosis and haemostasis : JTH 2006;4(8):1701-6.
-
2006: Martini C H; Brandts A; de Bruijne E L E; van Hylckama Vlieg A; Leebeek F W G; Lisman T; Rosendaal F R
The effect of genetic variants in the thrombin activatable fibrinolysis inhibitor (TAFI) gene on TAFI-antigen levels, clot lysis time and the risk of venous thrombosis.
British journal of haematology 2006;134(1):92-4.
-
2006: Plug Iris; Mauser-Bunschoten Eveline P; Bröcker-Vriends Annette H J T; van Amstel Hans Kristian Ploos; van der Bom Johanna G; van Diemen-Homan Joanna E M; Willemse José; Rosendaal Frits R
Bleeding in carriers of hemophilia.
Blood 2006;108(1):52-6.
-
2006: Nossent A Yaël; Eikenboom Jeroen C J; Vos Hans L; Bakker Egbert; Tanis Bea C; Doggen Carine J M; Bertina Rogier M; Rosendaal Frits R
Haplotypes encoding the factor VIII 1241 Glu variation, factor VIII levels and the risk of venous thrombosis.
Thrombosis and haemostasis 2006;95(6):942-8.
-
2006: Kornaat Peter R; Bloem Johan L; Ceulemans Ruth Y T; Riyazi Naghmeh; Rosendaal Frits R; Nelissen Rob G; Carter Wayne O; Hellio Le Graverand Marie-Pierre; Kloppenburg Margreet
Osteoarthritis of the knee: association between clinical features and MR imaging findings.
Radiology 2006;239(3):811-7.
-
2006: Garcia A A; van der Heijden J F; Meijers J C M; Rosendaal F R; Reitsma P H
The relationship between ABO blood group and the risk of bleeding during vitamin K antagonist treatment.
Journal of thrombosis and haemostasis : JTH 2006;4(6):1418-20.
-
2006: Curb J David; Prentice Ross L; Bray Paul F; Langer Robert D; Van Horn Linda; Barnabei Vanessa M; Bloch Michael J; Cyr Michele G; Gass Margery; Lepine Lisa; Rodabough Rebecca J; Sidney Stephen; Uwaifo Gabriel I; Rosendaal Frits R
Venous thrombosis and conjugated equine estrogen in women without a uterus.
Archives of internal medicine 2006;166(7):772-80.
-
2006: Schreijer A J M; Cannegieter S C; Meijers J C M; Middeldorp S; Büller H R; Rosendaal F R
Activation of coagulation system during air travel: a crossover study.
Lancet 2006;367(9513):832-8.
-
2006: Vossen C Y; Hasstedt S J; Scott B T; Rosendaal F R; Bovill E G
A genome search for genetic determinants of markers of protein C activation.
Journal of thrombosis and haemostasis : JTH 2006;4(3):706-8.
-
2006: Rombouts E K; Rosendaal F R; van der Meer F J M
The effect of vitamin K supplementation on anticoagulant treatment.
Journal of thrombosis and haemostasis : JTH 2006;4(3):691-2.
-
2006: Blom J W; Vanderschoot J P M; Oostindiër M J; Osanto S; van der Meer F J M; Rosendaal F R
Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study.
Journal of thrombosis and haemostasis : JTH 2006;4(3):529-35.
-
2006: Plug I; Van Der Bom J G; Peters M; Mauser-Bunschoten E P; De Goede-Bolder A; Heijnen L; Smit C; Willemse J; Rosendaal F R
Mortality and causes of death in patients with hemophilia, 1992-2001: a prospective cohort study.
Journal of thrombosis and haemostasis : JTH 2006;4(3):510-6.
-
2006: Uitte DE Willige S; Doggen C J M; DE Visser M C H; Bertina R M; Rosendaal F R
Haplotypes of the fibrinogen gamma gene do not affect the risk of myocardial infarction.
Journal of thrombosis and haemostasis : JTH 2006;4(2):474-6.
-
2006: Dahm Anders; Rosendaal Frits R; Andersen Trine O; Sandset Per M
Tissue factor pathway inhibitor anticoagulant activity: risk for venous thrombosis and effect of hormonal state.
British journal of haematology 2006;132(3):333-8.
-
2006: Blom J W; Osanto S; Rosendaal F R
High risk of venous thrombosis in patients with pancreatic cancer: a cohort study of 202 patients.
European journal of cancer (Oxford, England : 1990) 2006;42(3):410-4.
-
2006: Valkenburg-van den Berg Arijaan W; Sprij Arwen J; Oostvogel Paul M; Mutsaers Johan A E M; Renes Wouter B; Rosendaal Frits R; Joep Dörr P
Prevalence of colonisation with group B Streptococci in pregnant women of a multi-ethnic population in The Netherlands.
European journal of obstetrics, gynecology, and reproductive biology 2006;124(2):178-83.
-
2006: Naess I A; Christiansen S C; Cannegieter S C; Rosendaal F R; Hammerstroem J
A prospective study of anticardiolipin antibodies as a risk factor for venous thrombosis in a general population (the HUNT study).
Journal of thrombosis and haemostasis : JTH 2006;4(1):44-9.
-
2006: Vriesendorp Titia M; van Santen Susanne; DeVries J Hans; de Jonge Evert; Rosendaal Frits R; Schultz Marcus J; Hoekstra Joost B L
Predisposing factors for hypoglycemia in the intensive care unit.
Critical care medicine 2006;34(1):96-101.
-
2005: Uitte de Willige Shirley; de Visser Marieke C H; Houwing-Duistermaat Jeanine J; Rosendaal Frits R; Vos Hans L; Bertina Rogier M
Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen gamma' levels.
Blood 2005;106(13):4176-83.
-
2005: Schreijer Anja J M; Cannegieter Suzanne C; Rosendaal F R; Helmerhorst Frans M
A case of thrombosis at high altitude.
Thrombosis and haemostasis 2005;94(5):1104-5.
-
2005: Brummel-Ziedins K E; Vossen C Y; Butenas S; Mann K G; Rosendaal F R
Thrombin generation profiles in deep venous thrombosis.
Journal of thrombosis and haemostasis : JTH 2005;3(11):2497-505.
-
2005: Komanasin N; Catto A J; Futers T S; van Hylckama Vlieg A; Rosendaal F R; Ariëns R A S
A novel polymorphism in the factor XIII B-subunit (His95Arg): relationship to subunit dissociation and venous thrombosis.
Journal of thrombosis and haemostasis : JTH 2005;3(11):2487-96.
-
2005: Blom J W; Doggen C J M; Osanto S; Rosendaal F R
Old and new risk factors for upper extremity deep venous thrombosis.
Journal of thrombosis and haemostasis : JTH 2005;3(11):2471-8.
-
2005: van Korlaar I M; Vossen C Y; Rosendaal F R; Bovill E G; Naud S; Cameron L D; Kaptein A A
Attitudes toward genetic testing for thrombophilia in asymptomatic members of a large family with heritable protein C deficiency.
Journal of thrombosis and haemostasis : JTH 2005;3(11):2437-44.
-
2005: Rooden C J; Tesselaar M E T; Osanto S; Rosendaal F R; Huisman M V
Deep vein thrombosis associated with central venous catheters - a review.
Journal of thrombosis and haemostasis : JTH 2005;3(11):2409-19.
-
2005: Reitsma Pieter H; van der Heijden Jeroen F; Groot Angelique P; Rosendaal Frits R; Büller Harry R
A C1173T dimorphism in the VKORC1 gene determines coumarin sensitivity and bleeding risk.
PLoS medicine 2005;2(10):e312.
-
2005: van Stralen K J; Blom J W; Doggen C J M; Rosendaal F R
Strenuous sport activities involving the upper extremities increase the risk of venous thrombosis of the arm.
Journal of thrombosis and haemostasis : JTH 2005;3(9):2110-1.
-
2005: de Groot P G; Lutters B; Derksen R H W M; Lisman T; Meijers J C M; Rosendaal F R
Lupus anticoagulants and the risk of a first episode of deep venous thrombosis.
Journal of thrombosis and haemostasis : JTH 2005;3(9):1993-7.
-
2005: Vossen Carla Y; Walker Isobel D; Svensson Peter; Souto Juan C; Scharrer Inge; Preston F Eric; Palareti Gualtiero; Pabinger Ingrid; van der Meer Felix J M; Makris Mike; Fontcuberta Jordi; Conard Jacqueline; Rosendaal Frits R
Recurrence rate after a first venous thrombosis in patients with familial thrombophilia.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(9):1992-7.
-
2005: Torn Marieke; Bollen Ward L E M; van der Meer Felix J M; van der Wall Ernst E; Rosendaal Frits R
Risks of oral anticoagulant therapy with increasing age.
Archives of internal medicine 2005;165(13):1527-32.
-
2005: de Visser M C H; van Hylckama Vlieg A; Tans G; Rosing J; Dahm A E A; Sandset P M; Rosendaal F R; Bertina R M
Determinants of the APTT- and ETP-based APC sensitivity tests.
Journal of thrombosis and haemostasis : JTH 2005;3(7):1488-94.
-
2005: Brummel-Ziedins K; Vossen C Y; Rosendaal F R; Umezaki K; Mann K G
The plasma hemostatic proteome: thrombin generation in healthy individuals.
Journal of thrombosis and haemostasis : JTH 2005;3(7):1472-81.
-
2005: Emmerich J; Vossen C Y; Callas P W; Demers C; Naud S; Long G L; Couture P; Rosendaal F R; Bovill E G
Chronic venous abnormalities in symptomatic and asymptomatic protein C deficiency.
Journal of thrombosis and haemostasis : JTH 2005;3(7):1428-31.
-
2005: Posthouwer Dirk; Plug Iris; van der Bom Johanna G; Fischer Kathelijn; Rosendaal Frits R; Mauser-Bunschoten Eveline P
Hepatitis C and health-related quality of life among patients with hemophilia.
Haematologica 2005;90(6):846-50.
-
2005: Slooter A J C; Rosendaal F R; Tanis B C; Kemmeren J M; van der Graaf Y; Algra A
Prothrombotic conditions, oral contraceptives, and the risk of ischemic stroke.
Journal of thrombosis and haemostasis : JTH 2005;3(6):1213-7.
-
2005: van Minkelen Rick; de Visser Marieke C H; Vos Hans L; Bertina Rogier M; Rosendaal Frits R
The Marburg I polymorphism of factor VII-activating protease is not associated with venous thrombosis.
Blood 2005;105(12):4898; author reply 4899.
-
2005: Christiansen Sverre C; Cannegieter Suzanne C; Koster Ted; Vandenbroucke Jan P; Rosendaal Frits R
Thrombophilia, clinical factors, and recurrent venous thrombotic events.
JAMA : the journal of the American Medical Association 2005;293(19):2352-61.
-
2005: Riyazi Naghmeh; Slagboom Eline; de Craen Anton J M; Meulenbelt Ingrid; Houwing-Duistermaat Jeanine J; Kroon Herman M; van Schaardenburg Dirkjan; Rosendaal Frits R; Breedveld Ferdinand C; Huizinga Tom W J; Kloppenburg Margreet
Association of the risk of osteoarthritis with high innate production of interleukin-1beta and low innate production of interleukin-10 ex vivo, upon lipopolysaccharide stimulation.
Arthritis and rheumatism 2005;52(5):1443-50.
-
2005: Posthouwer D; Plug I; van der Bom J G; Fischer K; Rosendaal F R; Mauser-Bunschoten E P
Hepatitis C infection among Dutch haemophilia patients: a nationwide cross-sectional study of prevalence and antiviral treatment.
Haemophilia : the official journal of the World Federation of Hemophilia 2005;11(3):270-5.
-
2005: Pasterkamp E; Kruithof C J; Van der Meer F J M; Rosendaal F R; Vanderschoot J P M
A model-based algorithm for the monitoring of long-term anticoagulation therapy.
Journal of thrombosis and haemostasis : JTH 2005;3(5):915-21.
-
2005: Dahm A E A; Andersen T O; Rosendaal F; Sandset P M
A novel anticoagulant activity assay of tissue factor pathway inhibitor I (TFPI).
Journal of thrombosis and haemostasis : JTH 2005;3(4):651-8.
-
2005: van Rooden Cornelis J; Schippers Emile F; Barge Renée M Y; Rosendaal Frits R; Guiot Henri F L; van der Meer Felix J M; Meinders A Edo; Huisman Menno V
Infectious complications of central venous catheters increase the risk of catheter-related thrombosis in hematology patients: a prospective study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(12):2655-60.
-
2005: Bertina R M; Poort S R; Vos H L; Rosendaal F R
The 46C-->T polymorphism in the factor XII gene (F12) and the risk of venous thrombosis.
Journal of thrombosis and haemostasis : JTH 2005;3(3):597-9.
-
2005: Vossen C Y; Conard J; Fontcuberta J; Makris M; VAN DER Meer F J M; Pabinger I; Palareti G; Preston F E; Scharrer I; Souto J C; Svensson P; Walker I D; Rosendaal F R
Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT).
Journal of thrombosis and haemostasis : JTH 2005;3(3):459-64.
-
2005: Al-Shanqeeti Ali; van Hylckama Vlieg Astrid; Berntorp Erik; Rosendaal Frits R; Broze George J
Protein Z and protein Z-dependent protease inhibitor. Determinants of levels and risk of venous thrombosis.
Thrombosis and haemostasis 2005;93(3):411-3.
-
2005: de Galan-Roosen Agnes E M; Kuijpers Johan C; Rosendaal Frits R; Steegers Eric A; van Beers Wil A; Ponjee Gabriëlle A; Merkus Hans M
Maternal and paternal thrombophilia: risk factors for perinatal mortality.
BJOG : an international journal of obstetrics and gynaecology 2005;112(3):306-11.
-
2005: van Dunné F M; Doggen C J M; Heemskerk M; Rosendaal F R; Helmerhorst F M
Factor V Leiden mutation in relation to fecundity and miscarriage in women with venous thrombosis.
Human reproduction (Oxford, England) 2005;20(3):802-6.
-
2005: Wettinger Stephanie Bezzina; Doggen Carine J M; Spek C Arnold; Rosendaal Frits R; Reitsma Pieter H
High throughput mRNA profiling highlights associations between myocardial infarction and aberrant expression of inflammatory molecules in blood cells.
Blood 2005;105(5):2000-6.
-
2005: Riyazi N; Meulenbelt I; Kroon H M; Ronday K H; Hellio le Graverand M-P; Rosendaal F R; Breedveld F C; Slagboom P E; Kloppenburg M
Evidence for familial aggregation of hand, hip, and spine but not knee osteoarthritis in siblings with multiple joint involvement: the GARP study.
Annals of the rheumatic diseases 2005;64(3):438-43.
-
2005: Blom Jeanet W; Doggen Carine J M; Osanto Susanne; Rosendaal Frits R
Malignancies, prothrombotic mutations, and the risk of venous thrombosis.
JAMA : the journal of the American Medical Association 2005;293(6):715-22.
-
2005: Nossent A Y; Dai L; Rosendaal F R; Vos H L; Eikenboom J C J
Beta 2 adrenergic receptor polymorphisms: association with factor VIII and von Willebrand factor levels and the risk of venous thrombosis.
Journal of thrombosis and haemostasis : JTH 2005;3(2):405-7.
-
2005: van Vliet Huib A A M; Frolich Marijke; Christella M; Thomassen L G D; Doggen Carine J M; Rosendaal Frits R; Rosing Jan; Helmerhorst Frans M
Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogens.
Human reproduction (Oxford, England) 2005;20(2):563-8.
-
2005: Lisman Ton; de Groot Philip G; Meijers Joost C M; Rosendaal Frits R
Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis.
Blood 2005;105(3):1102-5.
-
2005: Rosendaal Frits R
Venous thrombosis: the role of genes, environment, and behavior.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2005;():1-12.
-
2005: Witsenburg C P J; Rosendaal F R; Middeldorp J M; Van der Meer F J M; Scherjon S A
Factor VIII levels and the risk of pre-eclampsia, HELLP syndrome, pregnancy related hypertension and severe intrauterine growth retardation.
Thrombosis research 2005;115(5):387-92.
-
2004: Plug Iris; van der Bom Johanna G; Peters Marjolein; Mauser-Bunschoten Evelien P; de Goede-Bolder Arja; Heijnen Lily; Smit Cees; Zwart-van Rijkom Jeannette E F; Willemse José; Rosendaal Frits R
Thirty years of hemophilia treatment in the Netherlands, 1972-2001.
Blood 2004;104(12):3494-500.
-
2004: van Rooden Cornelis J; Molhoek Sander G; Rosendaal Frits R; Schalij Martin J; Meinders A Edo; Huisman Menno V
Incidence and risk factors of early venous thrombosis associated with permanent pacemaker leads.
Journal of cardiovascular electrophysiology 2004;15(11):1258-62.
-
2004: van Driel Dieneke; Wesseling Judit; ter Huurne Kirsten; Geven-Boere Lya M; Rosendaal Frits R; van der Veer Eveline; de Jong-van den Berg Lolkje T W
Adherence to a guideline for coumarins in pregnancy.
Pharmacy world & science : PWS 2004;26(5):297-300.
-
2004: Smith Nicholas L; Heckbert Susan R; Lemaitre Rozenn N; Reiner Alex P; Lumley Thomas; Weiss Noel S; Larson Eric B; Rosendaal Frits R; Psaty Bruce M
Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.
JAMA : the journal of the American Medical Association 2004;292(13):1581-7.
-
2004: Cushman Mary; Kuller Lewis H; Prentice Ross; Rodabough Rebecca J; Psaty Bruce M; Stafford Randall S; Sidney Steven; Rosendaal Frits R;
Estrogen plus progestin and risk of venous thrombosis.
JAMA : the journal of the American Medical Association 2004;292(13):1573-80.
-
2004: Blom J W; Osanto S; Rosendaal F R
The risk of a venous thrombotic event in lung cancer patients: higher risk for adenocarcinoma than squamous cell carcinoma.
Journal of thrombosis and haemostasis : JTH 2004;2(10):1760-5.
-
2004: Tesselaar M E T; Ouwerkerk J; Nooy M A; Rosendaal F R; Osanto S
Risk factors for catheter-related thrombosis in cancer patients.
European journal of cancer (Oxford, England : 1990) 2004;40(15):2253-9.
-
2004: Vossen Carla Y; Strandberg Karin; Stenflo Johan; Rosendaal Frits R; Callas Peter W; Long George L; Bovill Edwin G
No effect of the prothrombin G20210A mutation on protein C activation in a large kindred with type I protein C deficiency.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2004;15(7):573-6.
-
2004: Doggen Carine J M; Smith Nicholas L; Lemaitre Rozenn N; Heckbert Susan R; Rosendaal Frits R; Psaty Bruce M
Serum lipid levels and the risk of venous thrombosis.
Arteriosclerosis, thrombosis, and vascular biology 2004;24(10):1970-5.
-
2004: Vandenbroucke Jan P; Rosendaal Frits R
Factor V Leiden and venous thromboembolism.
Annals of internal medicine 2004;141(6):484.
-
2004: Vossen C Y; Conard J; Fontcuberta J; Makris M; Van Der Meer F J M; Pabinger I; Palareti G; Preston F E; Scharrer I; Souto J C; Svensson P; Walker I D; Rosendaal F R
Familial thrombophilia and lifetime risk of venous thrombosis.
Journal of thrombosis and haemostasis : JTH 2004;2(9):1526-32.
-
2004: Uitte de Willige S; Van Marion V; Rosendaal F R; Vos H L; de Visser M C H; Bertina R M
Haplotypes of the EPCR gene, plasma sEPCR levels and the risk of deep venous thrombosis.
Journal of thrombosis and haemostasis : JTH 2004;2(8):1305-10.
-
2004: Rosendaal Frits R
Risk of myocardial infarction associated with the use of oral contraception.
Contraception 2004;70(1):85; author reply 85-6.
-
2004: Schaar C G; Snijder S; Oostindiër M J; Rosendaal F R; Willemze R; Kluin-Nelemans J C
Monoclonal proteinaemia and solid tumours.
European journal of cancer (Oxford, England : 1990) 2004;40(10):1539-44.
-
2004: van der Neut Kolfschoten M; Dirven R J; Poort S R; van Wijk R; Vos H L; Rosendaal F R; Bertina R M
Characterization of an immunologic polymorphism (D79H) in the heavy chain of factor V.
Journal of thrombosis and haemostasis : JTH 2004;2(6):910-7.
-
2004: Hasstedt S J; Scott B T; Callas P W; Vossen C Y; Rosendaal F R; Long G L; Bovill E G
Genome scan of venous thrombosis in a pedigree with protein C deficiency.
Journal of thrombosis and haemostasis : JTH 2004;2(6):868-73.
-
2004: van Hylckama Vlieg Astrid; Sandkuijl Lodewijk A; Rosendaal Frits R; Bertina Rogier M; Vos Hans L
Candidate gene approach in association studies: would the factor V Leiden mutation have been found by this approach?
European journal of human genetics : EJHG 2004;12(6):478-82.
-
2004: Reitsma P H; Rosendaal F R
Activation of innate immunity in patients with venous thrombosis: the Leiden Thrombophilia Study.
Journal of thrombosis and haemostasis : JTH 2004;2(4):619-22.
-
2004: Vossen C Y; Preston F E; Conard J; Fontcuberta J; Makris M; van der Meer F J M; Pabinger I; Palareti G; Scharrer I; Souto J C; Svensson P; Walker I D; Rosendaal F R
Hereditary thrombophilia and fetal loss: a prospective follow-up study.
Journal of thrombosis and haemostasis : JTH 2004;2(4):592-6.
-
2004: Gadisseur A P A; Kaptein A A; Breukink-Engbers W G M; van der Meer F J M; Rosendaal F R
Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life.
Journal of thrombosis and haemostasis : JTH 2004;2(4):584-91.
-
2004: Torn Marieke; van der Meer Felix J M; Rosendaal Frits R
Lowering the intensity of oral anticoagulant therapy: effects on the risk of hemorrhage and thromboembolism.
Archives of internal medicine 2004;164(6):668-73.
-
2004: Van Rooden Cornelis J; Rosendaal Frits R; Meinders A Edo; Van Oostayen Jacques A; Van Der Meer Felix J M; Huisman Menno V
The contribution of factor V Leiden and prothrombin G20210A mutation to the risk of central venous catheter-related thrombosis.
Haematologica 2004;89(2):201-6.
-
2004: Rosendaal F R; Reitsma P H
Genetic studies in complex disease.
Journal of thrombosis and haemostasis : JTH 2004;2(2):342.
-
2004: Vossen C Y; Hasstedt S J; Rosendaal F R; Callas P W; Bauer K A; Broze G J; Hoogendoorn H; Long G L; Scott B T; Bovill E G
Heritability of plasma concentrations of clotting factors and measures of a prethrombotic state in a protein C-deficient family.
Journal of thrombosis and haemostasis : JTH 2004;2(2):242-7.
-
2004: Srámek A; Bucciarelli P; Federici A B; Mannucci P M; De Rosa V; Castaman G; Morfini M; Mazzucconi M G; Rocino A; Schiavoni M; Scaraggi F A; Reiber J H C; Rosendaal F R
Patients with type 3 severe von Willebrand disease are not protected against atherosclerosis: results from a multicenter study in 47 patients.
Circulation 2004;109(6):740-4.
-
2004: Darwish Murad Sarwa; Valla Dominique-Charles; de Groen Piet C; Zeitoun Guy; Hopmans Judith A M; Haagsma Elizabeth B; van Hoek Bart; Hansen Bettina E; Rosendaal Frits R; Janssen Harry L A
Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome.
Hepatology (Baltimore, Md.) 2004;39(2):500-8.
-
2004: Tanis B C; Blom H J; Bloemenkamp D G M; van den Bosch M A A J; Algra A; van der Graaf Y; Rosendaal F R
Folate, homocysteine levels, methylenetetrahydrofolate reductase (MTHFR) 677C --> T variant, and the risk of myocardial infarction in young women: effect of female hormones on homocysteine levels.
Journal of thrombosis and haemostasis : JTH 2004;2(1):35-41.
-
2004: Vossen Carla Y; van Korlaar Inez M; Cushman Mary; Rosendaal Frits R; Bovill Edwin G
Sensitivity of a questionnaire for data collection on venous thrombosis.
Thrombosis research 2004;114(4):259-63.
-
2004: van Korlaar Inez M; Vossen Carla Y; Rosendaal Frits R; Bovill Edwin G; Cushman Mary; Naud Shelly; Kaptein A A
The impact of venous thrombosis on quality of life.
Thrombosis research 2004;114(1):11-8.
-
2003: Schreijer A J M; Cannegieter S C; Rosendaal F R
Effect of prolonged sitting on thrombin generation: not evidenced yet: rebuttal.
Journal of thrombosis and haemostasis : JTH 2003;1(12):2700.
-
2003: Bis Joshua C; Smith Nicholas L; Psaty Bruce M; Heckbert Susan R; Edwards Karen L; Lemaitre Rozenn N; Lumley Thomas; Rosendaal Frits R
Angiotensinogen Met235Thr polymorphism, angiotensin-converting enzyme inhibitor therapy, and the risk of nonfatal stroke or myocardial infarction in hypertensive patients.
American journal of hypertension 2003;16(12):1011-7.
-
2003: Gadisseur A P A; Breukink-Engbers W G M; van der Meer F J M; van den Besselaar A M H; Sturk A; Rosendaal F R
Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial.
Archives of internal medicine 2003;163(21):2639-46.
-
2003: van Rooden Cornelis J; Rosendaal Frits R; Barge Renée M Y; van Oostayen Jacques A; van der Meer Felix J M; Meinders A Edo; Huisman Menno V
Central venous catheter related thrombosis in haematology patients and prediction of risk by screening with Doppler-ultrasound.
British journal of haematology 2003;123(3):507-12.
-
2003: Torn Marieke; Rosendaal Frits R
Oral anticoagulation in surgical procedures: risks and recommendations.
British journal of haematology 2003;123(4):676-82.
-
2003: Ricci Michael A; Emmerich Joseph; Callas Peter W; Rosendaal Frits R; Stanley Andrew C; Naud Shelly; Vossen Carla; Bovill Edwin G
Evaluating chronic venous disease with a new venous severity scoring system.
Journal of vascular surgery : official publication, the Society for Vascular Surgery [and] International Society for Cardiovascular Surgery, North American Chapter 2003;38(5):909-15.
-
2003: van den Bosch Maurice A A J; Bloemenkamp Daisy G M; Mali Willem P Th M; Kemmeren Jeanet M; Tanis Bea C; Algra Ale; Rosendaal Frits R; van der Graaf Yolanda
Hyperhomocysteinemia and risk for peripheral arterial occlusive disease in young women.
Journal of vascular surgery : official publication, the Society for Vascular Surgery [and] International Society for Cardiovascular Surgery, North American Chapter 2003;38(4):772-8.
-
2003: van Hylckama Vlieg A; Rosendaal F R
Interaction between oral contraceptive use and coagulation factor levels in deep venous thrombosis.
Journal of thrombosis and haemostasis : JTH 2003;1(10):2186-90.
-
2003: Lowe Gordon D O; Sandercock Peter A G; Rosendaal Frits R
Prevention of venous thromboembolism after major orthopaedic surgery: is fondaparinux an advance?
Lancet 2003;362(9383):504-5.
-
2003: Van Rooden C J; Monraats P S; Kettenis I M J; Rosendaal F R; Huisman M V
Low physician compliance of prescribing anticoagulant prophylaxis in patients with solid tumor or hematological malignancies and central vein catheters.
Journal of thrombosis and haemostasis : JTH 2003;1(8):1842-3.
-
2003: De Visser M C H; Sandkuijl L A; Lensen R P M; Vos H L; Rosendaal F R; Bertina R M
Linkage analysis of factor VIII and von Willebrand factor loci as quantitative trait loci.
Journal of thrombosis and haemostasis : JTH 2003;1(8):1771-6.
-
2003: Rosendaal F R
Genetic studies in complex disease: the case pro association studies.
Journal of thrombosis and haemostasis : JTH 2003;1(8):1679-80.
-
2003: Srámek A; Kriek M; Rosendaal F R
Decreased mortality of ischaemic heart disease among carriers of haemophilia.
Lancet 2003;362(9381):351-4.
-
2003: Fihn Stephan D; Gadisseur Alain A P; Pasterkamp Edwin; van der Meer Felix J M; Breukink-Engbers W G Mimi; Geven-Boere Lya M; van Meegen Erik; de Vries-Goldschmeding Hanneke; Antheunissen-Anneveld Irma; van't Hoff Annelies R; Harderman Derk; Smink Margriet; Rosendaal Frits R
Comparison of control and stability of oral anticoagulant therapy using acenocoumarol versus phenprocoumon.
Thrombosis and haemostasis 2003;90(2):260-6.
-
2003: Tanis Bea C; Bloemenkamp Daisy G M; van den Bosch Maurice A A J; Kemmeren Jeanet M; Algra Ale; van de Graaf Yolanda; Rosendaal Frits R
Prothrombotic coagulation defects and cardiovascular risk factors in young women with acute myocardial infarction.
British journal of haematology 2003;122(3):471-8.
-
2003: Tans Guido; van Hylckama Vlieg Astrid; Thomassen M Christella L G D; Curvers Joyce; Bertina Rogier M; Rosing Jan; Rosendaal Frits R
Activated protein C resistance determined with a thrombin generation-based test predicts for venous thrombosis in men and women.
British journal of haematology 2003;122(3):465-70.
-
2003: Rosendaal F R; Van Hylckama Vlieg A; Tanis B C; Helmerhorst F M
Estrogens, progestogens and thrombosis.
Journal of thrombosis and haemostasis : JTH 2003;1(7):1371-80.
-
2003: Reiner Alexander P; Heckbert Susan R; Vos Hans L; Ariëns Robert A S; Lemaitre Rozenn N; Smith Nicholas L; Lumley Thomas; Rea Thomas D; Hindorff Lucia A; Schellenbaum Gina D; Rosendaal Frits R; Siscovick David S; Psaty Bruce M
Genetic variants of coagulation factor XIII, postmenopausal estrogen therapy, and risk of nonfatal myocardial infarction.
Blood 2003;102(1):25-30.
-
2003: Bloemenkamp Kitty W M; Helmerhorst Frans M; Rosendaal Frits R; Vandenbroucke Jan P
Thrombophilias and gynaecology.
Best practice & research. Clinical obstetrics & gynaecology 2003;17(3):509-28.
-
2003: Gadisseur A P A; Van Der Meer F J M; Rosendaal F R
Sustained intake of paracetamol (acetaminophen) during oral anticoagulant therapy with coumarins does not cause clinically important INR changes: a randomized double-blind clinical trial.
Journal of thrombosis and haemostasis : JTH 2003;1(4):714-7.
-
2003: Rosendaal F R
Clotting and myocardial infarction: a cycle of insights.
Journal of thrombosis and haemostasis : JTH 2003;1(4):640-2.
-
2003: Van Hylckama Vlieg A; Callas P W; Cushman M; Bertina R M; Rosendaal F R
Inter-relation of coagulation factors and d-dimer levels in healthy individuals.
Journal of thrombosis and haemostasis : JTH 2003;1(3):516-22.
-
2003: Van Den Bosch M A A J; Kemmeren J M; Tanis B C; Mali W P Th M; Helmerhorst F M; Rosendaal F R; Algra A; Van Der Graaf Y
The RATIO study: oral contraceptives and the risk of peripheral arterial disease in young women.
Journal of thrombosis and haemostasis : JTH 2003;1(3):439-44.
-
2003: Abdollahi Morteza; Cushman Mary; Rosendaal Frits R
Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use.
Thrombosis and haemostasis 2003;89(3):493-8.
-
2003: Tanis Bea C; Rosendaal Frits R
Venous and arterial thrombosis during oral contraceptive use: risks and risk factors.
Seminars in vascular medicine 2003;3(1):69-84.
-
2003: Srámek A; Reiber J H C; Baak-Pablo R; Sturk A; Rosendaal F R
Lipoprotein(a) and ultrasonographically determined early atherosclerotic changes in the carotid and femoral artery.
Journal of thrombosis and haemostasis : JTH 2003;1(2):374-9.
-
2002: Bucciarelli P; Srámek A; Reiber J H C; Rosendaal F R
Arterial intima-media thickness and its relationship with cardiovascular disease and atherosclerosis: a possible contribution of medium-sized arteries.
Thrombosis and haemostasis 2002;88(6):961-6.
-
2002: Penning-van Beest F J; Gómez García E B; van der Meer F J; van Meegen E; Rosendaal F R; Stricker B H
Levels of vitamin K-dependent procoagulant and anticoagulant proteins in over-anticoagulated patients.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2002;13(8):733-9.
-
2002: Keijzer Miranda B A J; den Heijer Martin; Blom Henk J; Bos Gerard M J; Willems Huub P J; Gerrits Wim B J; Rosendaal Frits R
Interaction between hyperhomocysteinemia, mutated methylenetetrahydrofolatereductase (MTHFR) and inherited thrombophilic factors in recurrent venous thrombosis.
Thrombosis and haemostasis 2002;88(5):723-8.
-
2002: Goodwin Andrew J; Rosendaal Frits R; Kottke-Marchant Kandice; Bovill Edwin G
A review of the technical, diagnostic, and epidemiologic considerations for protein S assays.
Archives of pathology & laboratory medicine 2002;126(11):1349-66.
-
2002: Zwart-van Rijkom J E F; Plug I; Rosendaal F R; Leufkens H G M; Broekmans A W;
The uptake of recombinant Factor VIII in the Netherlands.
British journal of haematology 2002;119(2):332-41.
-
2002: Bloemenkamp Daisy G M; van den Bosch Maurice A A J; Mali Willem P Th M; Tanis Bea C; Rosendaal Frits R; Kemmeren Jeanet M; Algra Ale; Visseren Frank L J; van der Graaf Yolanda
Novel risk factors for peripheral arterial disease in young women.
The American journal of medicine 2002;113(6):462-7.
-
2002: Van Hylckama Vlieg Astrid; Komanasin Nantarat; Ariëns Robert A S; Poort Swibertus R; Grant Peter J; Bertina Rogier M; Rosendaal Frits R
Factor XIII Val34Leu polymorphism, factor XIII antigen levels and activity and the risk of deep venous thrombosis.
British journal of haematology 2002;119(1):169-75.
-
2002: Rosendaal F R
Air travel and thrombosis.
Pathophysiology of haemostasis and thrombosis 2002;32(5-6):341-2.
-
2002: de Visser Marieke C H; Souverijn John H M; Rosendaal Frits R; Bertina Rogier M
The effect of plasma caeruloplasmin levels on the sensitivity for activated protein C.
British journal of haematology 2002;118(3):843-6.
-
2002: van den Bosch Maurice A A J; Mali Willem P Th M; Bloemenkamp Daisy G M; Eikelboom Bert C; Kemmeren Jeanet M; Tanis Bea C; Algra Ale; Rosendaal Frits R; van der Graaf Yolanda
Increased pregnancy loss in young women with aortoiliac disease.
Atherosclerosis 2002;164(1):121-7.
-
2002: Bloemenkamp D G M; Mali W P Th M; Tanis B C; Rosendaal F R; van den Bosch M A A J; Kemmeren J M; Algra A; Visseren F L J; van der Graaf Y
The relation between Helicobacter pylori and atherosclerosis cannot be explained by a high homocysteine concentration.
European journal of clinical investigation 2002;32(8):549-55.
-
2002: Meijers Joost C M; Marquart J Arnoud; Bertina Rogier M; Bouma Bonno N; Rosendaal Frits R
Protein C inhibitor (plasminogen activator inhibitor-3) and the risk of venous thrombosis.
British journal of haematology 2002;118(2):604-9.
-
2002: Poort S R; Vos H L; Rosendaal F R; Bertina R M
The endothelial protein C receptor (EPCR) 23 bp insert mutation and the risk of venous thrombosis.
Thrombosis and haemostasis 2002;88(1):160-2.
-
2002: Reiner Alexander P; Rosendaal Frits R; Reitsma Pieter H; Lemaitre Rozenn N; Pearce Rachel M; Friedlander Yechiel; Raghunathan Trivellore E; Psaty Bruce M; Siscovick David S
Factor V Leiden, prothrombin G20210A, and risk of sudden coronary death in apparently healthy persons.
The American journal of cardiology 2002;90(1):66-8.
-
2002: Bloemenkamp Daisy G M; Mali Willem P Th M; Tanis Bea C; Rosendaal Frits R; van den Bosch Maurice A A J; Kemmeren Jeanet M; Algra Ale; Ossewaarde Jacobus M; Visseren Frank L J; van Loon Anton M; van der Graaf Yolanda
Chlamydia pneumoniae, Helicobacter pylori and cytomegalovirus infections and the risk of peripheral arterial disease in young women.
Atherosclerosis 2002;163(1):149-56.
-
2002: Lemaitre Rozenn N; Psaty Bruce M; Heckbert Susan R; Smith Nicholas L; Longstreth W T; Rosendaal Frits R
Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal ischemic stroke in postmenopausal women.
Arteriosclerosis, thrombosis, and vascular biology 2002;22(6):1051-2.
-
2002: Gadisseur Alain P A; van der Meer Felix J M; Adriaansen Henk J; Fihn Stephan D; Rosendaal Frits R
Therapeutic quality control of oral anticoagulant therapy comparing the short-acting acenocoumarol and the long-acting phenprocoumon.
British journal of haematology 2002;117(4):940-6.
-
2002: Kaplan Robert C; Heckbert Susan R; Koepsell Thomas D; Rosendaal Frits R; Furberg Curt D; Cooper Lawton S; Psaty Bruce M;
Calcium channel blocker use and gastrointestinal tract bleeding among older adults.
Age and ageing 2002;31(3):217-8.
-
2002: Kemmeren Jeanet M; Tanis Bea C; van den Bosch Maurice A A J; Bollen Edward L E M; Helmerhorst Frans M; van der Graaf Yolanda; Rosendaal Frits R; Algra Ale
Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) study: oral contraceptives and the risk of ischemic stroke.
Stroke; a journal of cerebral circulation 2002;33(5):1202-8.
-
2002: Penning-van Beest Fernie J A; Geleijnse Johanna M; van Meegen Erik; Vermeer Cees; Rosendaal Frits R; Stricker Bruno H C
Lifestyle and diet as risk factors for overanticoagulation.
Journal of clinical epidemiology 2002;55(4):411-7.
-
2002: Psaty Bruce M; Smith Nicholas L; Heckbert Susan R; Vos Hans L; Lemaitre Rozenn N; Reiner Alexander P; Siscovick David S; Bis Joshua; Lumley Thomas; Longstreth W T; Rosendaal Frits R
Diuretic therapy, the alpha-adducin gene variant, and the risk of myocardial infarction or stroke in persons with treated hypertension.
JAMA : the journal of the American Medical Association 2002;287(13):1680-9.
-
2002: Curvers Joyce; Christella M; Thomassen L G D; de Ronde Hans; Bertina Rogier M; Rosendaal Frits R; Tans Guido; Rosing Jan
Effects of (pre-)analytical variables on activated protein C resistance determined via a thrombin generation-based assay.
Thrombosis and haemostasis 2002;87(3):483-92.
-
2002: Rosendaal F R; Vessey M; Rumley A; Daly E; Woodward M; Helmerhorst F M; Lowe G D O
Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis.
British journal of haematology 2002;116(4):851-4.
-
2002: Rosendaal F R; Bovill E G
Heritability of clotting factors and the revival of the prothrombotic state.
Lancet 2002;359(9307):638-9.
-
2002: Eikenboom Jeroen C J; Castaman Giancarlo; Kamphuisen Pieter W; Rosendaal Frits R; Bertina Rogier M
The factor VIII/von Willebrand factor ratio discriminates between reduced synthesis and increased clearance of von Willebrand factor.
Thrombosis and haemostasis 2002;87(2):252-7.
-
2002: Reiner Alexander P; Frank Michele B; Schwartz Stephen M; Linenberger Michael L; Longstreth W T; Teramura Gayle; Rosendaal Frits R; Psaty Bruce M; Siscovick David S
Coagulation factor XIII polymorphisms and the risk of myocardial infarction and ischaemic stroke in young women.
British journal of haematology 2002;116(2):376-82.
-
2002: Rosendaal F R; Helmerhorst F M; Vandenbroucke J P
Female hormones and thrombosis.
Arteriosclerosis, thrombosis, and vascular biology 2002;22(2):201-10.
-
2002: Andreescu Astrid C M; Cushman Mary; Rosendaal Frits R
D-dimer as a risk factor for deep vein thrombosis: the Leiden Thrombophilia Study.
Thrombosis and haemostasis 2002;87(1):47-51.
-
2002: van Aken Benien E; Reitsma Pieter H; Rosendaal Frits R
Interleukin 8 and venous thrombosis: evidence for a role of inflammation in thrombosis.
British journal of haematology 2002;116(1):173-7.
-
2002: Bauer Kenneth A; Rosendaal Frits R; Heit John A
Hypercoagulability: too many tests, too much conflicting data.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2002;():353-68.
-
2001: Tanis B C; van den Bosch M A; Kemmeren J M; Cats V M; Helmerhorst F M; Algra A; van der Graaf Y; Rosendaal F R
Oral contraceptives and the risk of myocardial infarction.
The New England journal of medicine 2001;345(25):1787-93.
-
2001: Torn M; Algra A; Rosendaal F R
Oral anticoagulation for cerebral ischemia of arterial origin: high initial bleeding risk.
Neurology 2001;57(11):1993-9.
-
2001: Reiner A P; Schwartz S M; Frank M B; Longstreth W T; Hindorff L A; Teramura G; Rosendaal F R; Gaur L K; Psaty B M; Siscovick D S
Polymorphisms of coagulation factor XIII subunit A and risk of nonfatal hemorrhagic stroke in young white women.
Stroke; a journal of cerebral circulation 2001;32(11):2580-6.
-
2001: Kamphuisen P W; Eikenboom J C; Rosendaal F R; Koster T; Blann A D; Vos H L; Bertina R M
High factor VIII antigen levels increase the risk of venous thrombosis but are not associated with polymorphisms in the von Willebrand factor and factor VIII gene.
British journal of haematology 2001;115(1):156-8.
-
2001: Couture P; Bovill E G; Demers C; Simard J; Delage R; Scott B T; Valliere J E; Callas P W; Jomphe M; Rosendaal F R; Aiach M; Long G L
Evidence of a founder effect for the protein C gene 3363 inserted C mutation in thrombophilic pedigrees of French origin.
Thrombosis and haemostasis 2001;86(4):1000-6.
-
2001: Reiner A P; Siscovick D S; Rosendaal F R
Platelet glycoprotein gene polymorphisms and risk of thrombosis: facts and fancies.
Reviews in clinical and experimental hematology 2001;5(3):262-87; discussion 311-2.
-
2001: Lensen R; Bertina R M; Vandenbroucke J P; Rosendaal F R
High factor VIII levels contribute to the thrombotic risk in families with factor V Leiden.
British journal of haematology 2001;114(2):380-6.
-
2001: Penning-van Beest F J; van Meegen E; Rosendaal F R; Stricker B H
Characteristics of anticoagulant therapy and comorbidity related to overanticoagulation.
Thrombosis and haemostasis 2001;86(2):569-74.
-
2001: Srámek A; Reiber J H; Gerrits W B; Rosendaal F R
Decreased coagulability has no clinically relevant effect on atherogenesis: observations in individuals with a hereditary bleeding tendency.
Circulation 2001;104(7):762-7.
-
2001: Rosendaal F R; Helmerhorst F M; Vandenbroucke J P
Oral contraceptives, hormone replacement therapy and thrombosis.
Thrombosis and haemostasis 2001;86(1):112-23.
-
2001: Ceelie H; Bertina R M; van Hylckama Vlieg A; Rosendaal F R; Vos H L
Polymorphisms in the prothrombin gene and their association with plasma prothrombin levels.
Thrombosis and haemostasis 2001;85(6):1066-70.
-
2001: de Visser M C; Poort S R; Vos H L; Rosendaal F R; Bertina R M
Factor X levels, polymorphisms in the promoter region of factor X, and the risk of venous thrombosis.
Thrombosis and haemostasis 2001;85(6):1011-7.
-
2001: Penning-van Beest F J; van Meegen E; Rosendaal F R; Stricker B H
Drug interactions as a cause of overanticoagulation on phenprocoumon or acenocoumarol predominantly concern antibacterial drugs.
Clinical pharmacology and therapeutics 2001;69(6):451-7.
-
2001: Friedlander Y; Arbogast P; Schwartz S M; Marcovina S M; Austin M A; Rosendaal F R; Reiner A P; Psaty B M; Siscovick D S
Family history as a risk factor for early onset myocardial infarction in young women.
Atherosclerosis 2001;156(1):201-7.
-
2001: Vandenbroucke J P; Rosing J; Bloemenkamp K W; Middeldorp S; Helmerhorst F M; Bouma B N; Rosendaal F R
Oral contraceptives and the risk of venous thrombosis.
The New England journal of medicine 2001;344(20):1527-35.
-
2001: Wesseling J; Van Driel D; Heymans H S; Rosendaal F R; Geven-Boere L M; Smrkovsky M; Touwen B C; Sauer P J; Van der Veer E
Coumarins during pregnancy: long-term effects on growth and development of school-age children.
Thrombosis and haemostasis 2001;85(4):609-13.
-
2001: Reiner A P; Siscovick D S; Rosendaal F R
Hemostatic risk factors and arterial thrombotic disease.
Thrombosis and haemostasis 2001;85(4):584-95.
-
2001: Reiner A P; Schwartz S M; Kumar P N; Rosendaal F R; Pearce R M; Aramaki K M; Psaty B M; Siscovick D S
Platelet glycoprotein IIb polymorphism, traditional risk factors and non-fatal myocardial infarction in young women.
British journal of haematology 2001;112(3):632-6.
-
2001: Psaty B M; Smith N L; Lemaitre R N; Vos H L; Heckbert S R; LaCroix A Z; Rosendaal F R
Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal women.
JAMA : the journal of the American Medical Association 2001;285(7):906-13.
-
2001: Frank M B; Reiner A P; Schwartz S M; Kumar P N; Pearce R M; Arbogast P G; Longstreth W T; Rosendaal F R; Psaty B M; Siscovick D S
The Kozak sequence polymorphism of platelet glycoprotein Ibalpha and risk of nonfatal myocardial infarction and nonfatal stroke in young women.
Blood 2001;97(4):875-9.
-
2000: Srámek A; Bosch J G; Reiber J H; Van Oostayen J A; Rosendaal F R
Ultrasound assessment of atherosclerotic vessel wall changes: reproducibility of intima-media thickness measurements in carotid and femoral arteries.
Investigative radiology 2000;35(12):699-706.
-
2000: Van Driel D; Wesseling J; Rosendaal F R; Odink R J; Van der Veer E; Gerver W J; Geven-Boere L M; Sauer P J
Growth until puberty after in utero exposure to coumarins.
American journal of medical genetics 2000;95(5):438-43.
-
2000: Doggen C J; de Visser M C; Vos H L; Bertina R M; Cats V M; Rosendaal F R
The HR2 haplotype of factor V is not associated with the risk of myocardial infarction.
Thrombosis and haemostasis 2000;84(5):815-8.
-
2000: Doggen C J; Berckmans R J; Sturk A; Manger Cats V; Rosendaal F R
C-reactive protein, cardiovascular risk factors and the association with myocardial infarction in men.
Journal of internal medicine 2000;248(5):406-14.
-
2000: Janssen H L; Meinardi J R; Vleggaar F P; van Uum S H; Haagsma E B; van Der Meer F J; van Hattum J; Chamuleau R A; Adang R P; Vandenbroucke J P; van Hoek B; Rosendaal F R
Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study.
Blood 2000;96(7):2364-8.
-
2000: Lensen R; Rosendaal F; Vandenbroucke J; Bertina R
Factor V Leiden: the venous thrombotic risk in thrombophilic families.
British journal of haematology 2000;110(4):939-45.
-
2000: Doggen C J; Bertina R M; Cats V M; Rosendaal F R
Fibrinogen polymorphisms are not associated with the risk of myocardial infarction.
British journal of haematology 2000;110(4):935-8.
-
2000: Zidane M; Schram M T; Planken E W; Molendijk W H; Rosendaal F R; van der Meer F J; Huisman M V
Frequency of major hemorrhage in patients treated with unfractionated intravenous heparin for deep venous thrombosis or pulmonary embolism: a study in routine clinical practice.
Archives of internal medicine 2000;160(15):2369-73.
-
2000: Reiner A P; Kumar P N; Schwartz S M; Longstreth W T; Pearce R M; Rosendaal F R; Psaty B M; Siscovick D S
Genetic variants of platelet glycoprotein receptors and risk of stroke in young women.
Stroke; a journal of cerebral circulation 2000;31(7):1628-33.
-
2000: Lensen R P; Bertina R M; de Ronde H; Vandenbroucke J P; Rosendaal F R
Venous thrombotic risk in family members of unselected individuals with factor V Leiden.
Thrombosis and haemostasis 2000;83(6):817-21.
-
2000: Kamphuisen P W; Lensen R; Houwing-Duistermaat J J; Eikenboom J C; Harvey M; Bertina R M; Rosendaal F R
Heritability of elevated factor VIII antigen levels in factor V Leiden families with thrombophilia.
British journal of haematology 2000;109(3):519-22.
-
2000: Kaplan R C; Heckbert S R; Koepsell T D; Rosendaal F R; Psaty B M
Use of calcium channel blockers and risk of hospitalized gastrointestinal tract bleeding.
Archives of internal medicine 2000;160(12):1849-55.
-
2000: van Hylckama Vlieg A; van der Linden I K; Bertina R M; Rosendaal F R
High levels of factor IX increase the risk of venous thrombosis.
Blood 2000;95(12):3678-82.
-
2000: Weijl N I; Rutten M F; Zwinderman A H; Keizer H J; Nooy M A; Rosendaal F R; Cleton F J; Osanto S
Thromboembolic events during chemotherapy for germ cell cancer: a cohort study and review of the literature.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(10):2169-78.
-
2000: Kamphuisen P W; Rosendaal F R; Eikenboom J C; Bos R; Bertina R M
Factor V antigen levels and venous thrombosis: risk profile, interaction with factor V leiden, and relation with factor VIII antigen levels.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(5):1382-6.
-
2000: van Tilburg N H; Rosendaal F R; Bertina R M
Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis.
Blood 2000;95(9):2855-9.
-
2000: de Visser M C; Guasch J F; Kamphuisen P W; Vos H L; Rosendaal F R; Bertina R M
The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis.
Thrombosis and haemostasis 2000;83(4):577-82.
-
2000: Eekhoff E M; Rosendaal F R; Vandenbroucke J P
Minor events and the risk of deep venous thrombosis.
Thrombosis and haemostasis 2000;83(3):408-11.
-
2000: Psaty B M; Doggen C; Vos H L; Vandenbroucke J P; Rosendaal F R
Association of the alpha-adducin polymorphism with blood pressure and risk of myocardial infarction.
Journal of human hypertension 2000;14(2):95-7.
-
2000: Rosendaal F R
High levels of factor VIII and venous thrombosis.
Thrombosis and haemostasis 2000;83(1):1-2.
-
1999: De Groot C J; Bloemenkamp K W; Duvekot E J; Helmerhorst F M; Bertina R M; Van Der Meer F; De Ronde H; Oei S G; Kanhai H H; Rosendaal F R
Preeclampsia and genetic risk factors for thrombosis: a case-control study.
American journal of obstetrics and gynecology 1999;181(4):975-80.
-
1999: van Boven H H; Vandenbroucke J P; Briët E; Rosendaal F R
Gene-gene and gene-environment interactions determine risk of thrombosis in families with inherited antithrombin deficiency.
Blood 1999;94(8):2590-4.
-
1999: Liberti G; Bertina R M; Rosendaal F R
Hormonal state rather than age influences cut-off values of protein S: reevaluation of the thrombotic risk associated with protein S deficiency.
Thrombosis and haemostasis 1999;82(3):1093-6.
-
1999: Bloemenkamp K W; Helmerhorst F M; Rosendaal F R; Vandenbroucke J P
Venous thrombosis, oral contraceptives and high factor VIII levels.
Thrombosis and haemostasis 1999;82(3):1024-7.
-
1999: Huisman M V; Rosendaal F
Thrombophilia.
Current opinion in hematology 1999;6(5):291-7.
-
1999: Rosendaal F R
Risk factors for venous thrombotic disease.
Thrombosis and haemostasis 1999;82(2):610-9.
-
1999: Psaty B M; Weiss N S; Furberg C D; Koepsell T D; Siscovick D S; Rosendaal F R; Smith N L; Heckbert S R; Kaplan R C; Lin D; Fleming T R; Wagner E H
Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease.
JAMA : the journal of the American Medical Association 1999;282(8):786-90.
-
1999: Doggen C J; Bertina R M; Cats V M; Reitsma P H; Rosendaal F R
The 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is not associated with myocardial infarction.
Thrombosis and haemostasis 1999;82(1):115-20.
-
1999: Kamphuisen P W; Eikenboom J C; Vos H L; Pablo R; Sturk A; Bertina R M; Rosendaal F R
Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions.
Thrombosis and haemostasis 1999;81(5):680-3.
-
1999: Cannegieter S C; Torn M; Rosendaal F R
Oral anticoagulant treatment in patients with mechanical heart valves: how to reduce the risk of thromboembolic and bleeding complications.
Journal of internal medicine 1999;245(4):369-74.
-
1999: Rosendaal F R
Venous thrombosis: a multicausal disease.
Lancet 1999;353(9159):1167-73.
-
1999: Bucciarelli P; Rosendaal F R; Tripodi A; Mannucci P M; De Stefano V; Palareti G; Finazzi G; Baudo F; Quintavalla R
Risk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated protein C resistance: a multicenter collaborative family study.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(4):1026-33.
-
1999: Willems H P; den Heijer M; Blom H J; Gerrits W B; Rosendaal F R; Bos G M
[Hyperhomocysteinemia as a risk factor for venous thrombosis]
Nederlands tijdschrift voor geneeskunde 1999;143(11):552-6.
-
1999: van der Meer F J; Vos H L; Rosendaal F R
No indication for APTT screening in patients on oral anticoagulant therapy.
Thrombosis and haemostasis 1999;81(3):364-6.
-
1999: Penning-van Beest F J; Rosendaal F R; Grobbee D E; van Meegen E; Stricker B H
Course of the international Normalized Ratio in response to oral vitamin K1 in patients overanticoagulated with phenprocoumon.
British journal of haematology 1999;104(2):241-5.
-
1999: de Visser M C; Rosendaal F R; Bertina R M
A reduced sensitivity for activated protein C in the absence of factor V Leiden increases the risk of venous thrombosis.
Blood 1999;93(4):1271-6.
-
1998: den Heijer M; Rosendaal F R; Blom H J; Gerrits W B; Bos G M
Hyperhomocysteinemia and venous thrombosis: a meta-analysis.
Thrombosis and haemostasis 1998;80(6):874-7.
-
1998: Helmerhorst F M; Rosendaal F R; Vandenbroucke J P
Venous thromboembolism and the pill. The WHO technical report on cardiovascular disease and steroid hormone contraception: state-of-the-art. World Health Organization.
Human reproduction (Oxford, England) 1998;13(11):2981-3.
-
1998: Doggen C J; Kunz G; Rosendaal F R; Lane D A; Vos H L; Stubbs P J; Manger Cats V; Ireland H
A mutation in the thrombomodulin gene, 127G to A coding for Ala25Thr, and the risk of myocardial infarction in men.
Thrombosis and haemostasis 1998;80(5):743-8.
-
1998: Bloemenkamp K W; Rosendaal F R; Helmerhorst F M; Koster T; Bertina R M; Vandenbroucke J P
Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
Thrombosis and haemostasis 1998;80(3):382-7.
-
1998: Doggen C J; Manger Cats V; Bertina R M; Reitsma P H; Vandenbroucke J P; Rosendaal F R
A genetic propensity to high factor VII is not associated with the risk of myocardial infarction in men.
Thrombosis and haemostasis 1998;80(2):281-5.
-
1998: Helmerhorst F M; Rosendaal F R; Vandenbroucke J P
The pill and venous thromboembolism: a disarray of several layers of debate.
Human reproduction (Oxford, England) 1998;13(5):1119-20.
-
1998: Cushman M; Rosendaal F R; Psaty B M; Cook E F; Valliere J; Kuller L H; Tracy R P
Factor V Leiden is not a risk factor for arterial vascular disease in the elderly: results from the Cardiovascular Health Study.
Thrombosis and haemostasis 1998;79(5):912-5.
-
1998: Rosendaal F R; Doggen C J; Zivelin A; Arruda V R; Aiach M; Siscovick D S; Hillarp A; Watzke H H; Bernardi F; Cumming A M; Preston F E; Reitsma P H
Geographic distribution of the 20210 G to A prothrombin variant.
Thrombosis and haemostasis 1998;79(4):706-8.
-
1998: Doggen C J; Cats V M; Bertina R M; Rosendaal F R
Interaction of coagulation defects and cardiovascular risk factors: increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A.
Circulation 1998;97(11):1037-41.
-
1998: den Heijer M; Brouwer I A; Bos G M; Blom H J; van der Put N M; Spaans A P; Rosendaal F R; Thomas C M; Haak H L; Wijermans P W; Gerrits W B
Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers.
Arteriosclerosis, thrombosis, and vascular biology 1998;18(3):356-61.
-
1998: Longstreth W T; Rosendaal F R; Siscovick D S; Vos H L; Schwartz S M; Psaty B M; Raghunathan T E; Koepsell T D; Reitsma P H
Risk of stroke in young women and two prothrombotic mutations: factor V Leiden and prothrombin gene variant (G20210A)
Stroke; a journal of cerebral circulation 1998;29(3):577-80.
-
1998: Kamphuisen P W; Houwing-Duistermaat J J; van Houwelingen H C; Eikenboom J C; Bertina R M; Rosendaal F R
Familial clustering of factor VIII and von Willebrand factor levels.
Thrombosis and haemostasis 1998;79(2):323-7.
-
1997: Schwartz S M; Siscovick D S; Malinow M R; Rosendaal F R; Beverly R K; Hess D L; Psaty B M; Longstreth W T; Koepsell T D; Raghunathan T E; Reitsma P H
Myocardial infarction in young women in relation to plasma total homocysteine, folate, and a common variant in the methylenetetrahydrofolate reductase gene.
Circulation 1997;96(2):412-7.
-
1997: Helmerhorst F M; Bloemenkamp K W; Rosendaal F R; Vandenbroucke J P
Oral contraceptives and thrombotic disease: risk of venous thromboembolism.
Thrombosis and haemostasis 1997;78(1):327-33.
-
1997: Siscovick D S; Schwartz S M; Rosendaal F R; Psaty B M
Thrombosis in the young: effect of atherosclerotic risk factors on the risk of myocardial infarction associated with prothrombotic factors.
Thrombosis and haemostasis 1997;78(1):7-12.
-
1997: Vandenbroucke J P; Rosendaal F R
End of the line for "third-generation-pill" controversy?
Lancet 1997;349(9059):1113-4.
-
1997: Rosendaal F R; Siscovick D S; Schwartz S M; Beverly R K; Psaty B M; Longstreth W T; Raghunathan T E; Koepsell T D; Reitsma P H
Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women.
Blood 1997;89(8):2817-21.
-
1997: Cannegieter S C; Rosendaal F R; Bollen E L; Briët E
High intensity of oral anticoagulant therapy in patients with cerebral haemorrhage: cause or consequence of the bleeding?
British journal of haematology 1997;96(3):497-9.
Sign-in to see more